BATS BZX Real-Time Price
As of 12:45pm ET
| +0.02 / +0.66%|
The 2 analysts offering 12-month price forecasts for Merrimack Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 15.00 and a low estimate of 3.00. The median estimate represents a +194.12% increase from the last price of 3.06.
The current consensus among 4 polled investment analysts is to Hold stock in Merrimack Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.